mRNA-1030

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1030, covering 2024-02-01 to 2024-02-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults [Phase 1, Phase 2]